Cash Equivalents - Arcellx Inc (NASDAQ:ACLX) - Alpha Spread
A

Arcellx Inc
NASDAQ:ACLX

Watchlist Manager
Arcellx Inc
NASDAQ:ACLX
Watchlist
Price: 86.61 USD 1.38% Market Closed
Market Cap: 4.6B USD
Have any thoughts about
Arcellx Inc?
Write Note

Arcellx Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcellx Inc
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Arcellx Inc
NASDAQ:ACLX
Cash Equivalents
$394.6m
CAGR 3-Years
104%
CAGR 5-Years
94%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$13.1B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$2.8B
CAGR 3-Years
-17%
CAGR 5-Years
-24%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9.3B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
8%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$4.6B
CAGR 3-Years
-9%
CAGR 5-Years
7%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$1.9B
CAGR 3-Years
-2%
CAGR 5-Years
13%
CAGR 10-Years
12%

See Also

What is Arcellx Inc's Cash Equivalents?
Cash Equivalents
394.6m USD

Based on the financial report for Dec 31, 2023, Arcellx Inc's Cash Equivalents amounts to 394.6m USD.

What is Arcellx Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
94%

Over the last year, the Cash Equivalents growth was 515%. The average annual Cash Equivalents growth rates for Arcellx Inc have been 104% over the past three years , 94% over the past five years .

Back to Top